COPSAC COPSAC COPSAC COPSAC
  • About COPSAC
    • About
    • Organization Diagram
    • Board of Directors
    • Research team
    • Location
    • Funding
    • Logo
    • Open positions
  • COPSAC cohorts
    • COPSAC2000 cohort
    • COPSAC2010 cohort
    • COPSACSEVERE cohort
    • COPSACACUTE cohort
    • Methods
    • Data overview
      • COPSAC2000 Clinic
      • COPSAC2000 Exposures
      • COPSAC2000 Omics
      • COPSAC2000 Biobank
      • COPSAC2010 Clinic
      • COPSAC2010 Exposures
      • COPSAC2010 Omics
      • COPSAC2010 Biobank
  • Dissemination
    • Theses
    • Literature for parents
  • Research Projects
    • RestoreGut
    • COPSYCH Research Alliance
    • HEDIMED Consortium
    • EDIAQI Consortium
    • EAGLE Consortium
    • EarlyVir
  • Strategy
  • ‌

Immortal news: Fish oil during pregnancy may cut children’s risk of developing asthma

    Home News Immortal news: Fish oil during pregnancy may cut children’s risk of developing asthma
    NextPrevious

    Immortal news: Fish oil during pregnancy may cut children’s risk of developing asthma

    By Dansk Børne Astma Center | News, PUFA | Comments are Closed | 30 December, 2016 |

    By Isabelle Jones

    A new clinical trial suggests that pregnant women to take fish oil during their third trimester may cut their kid’s risk for developing asthma by as much as one-third, according to an article by Tucson. The dose of fish oil given to the pregnant women was high, with fatty acid levels that were 15 to 20 times more than the average. There were no significant side effects, however, according to lead researcher Dr. Hans Bisgaard, a professor of pediatrics at the University of Copenhagen. For the study, Bisgaard’s team randomly assigned 736 pregnant women to take either fish oil or a placebo every day during the third trimester. The placebo capsules contained olive oil. The children in the fish oil group were about one-third less likely to develop asthma. By the age of five, nearly 17 percent of the children in the fish oil group were diagnosed with asthma or persistent wheezing, compared to the nearly 25 percent of the children in the placebo group.

    Read more

    No tags.
    NextPrevious

    CONTACT

    COPSAC
    Copenhagen Prospective Studies on Asthma in Childhood
    Copenhagen University Hospital, Herlev-Gentofte
    phone +45 3867 7360
    contact@copsac.com
    COPSAC • Copenhagen University Hospital, Herlev-Gentofte • Denmark © 2023
    • About COPSAC
      • About
      • Organization Diagram
      • Board of Directors
      • Research team
      • Location
      • Funding
      • Logo
      • Open positions
    • COPSAC cohorts
      • COPSAC2000 cohort
      • COPSAC2010 cohort
      • COPSACSEVERE cohort
      • COPSACACUTE cohort
      • Methods
      • Data overview
        • COPSAC2000 Clinic
        • COPSAC2000 Exposures
        • COPSAC2000 Omics
        • COPSAC2000 Biobank
        • COPSAC2010 Clinic
        • COPSAC2010 Exposures
        • COPSAC2010 Omics
        • COPSAC2010 Biobank
    • Dissemination
      • Theses
      • Literature for parents
    • Research Projects
      • RestoreGut
      • COPSYCH Research Alliance
      • HEDIMED Consortium
      • EDIAQI Consortium
      • EAGLE Consortium
      • EarlyVir
    • Strategy
    • ‌
    COPSAC